PP
AMGN icon

PagnatoKarp Partners’s Amgen AMGN Stock Holding History

PagnatoKarp Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,000
Closed -$21K – 185
2019
Q2 		$21K Hold
2,000
– – ﹤0.01% 190
2019
Q1 		$21K Hold
2,000
– – ﹤0.01% 186
2018
Q4 		$20K Hold
2,000
– – ﹤0.01% 164
2018
Q3 		$20K Buy
+2,000
New +$394K 0.01% 177

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PagnatoKarp Partners's AMGN Position: Q2 2020 in Review

PagnatoKarp Partners sold out of Amgen (AMGN) in Q2 2020, closing a stake of 2,079 shares — an estimated $421K sold.

PagnatoKarp Partners first reported a position in AMGN in Q2 2018 and held it in 8 quarters. The position peaked at $506K in Q4 2019. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • PagnatoKarp Partners reported no remaining Amgen position as of Q2 2020 after selling out during the quarter.
  • PagnatoKarp Partners sold 2,079 Amgen shares in Q2 2020, an estimated $421K.
  • PagnatoKarp Partners first reported a position in Amgen in Q2 2018 and held it in 8 quarters.
  • PagnatoKarp Partners's Amgen position peaked at $506K in Q4 2019.
  • 2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on PagnatoKarp Partners's 13F filing for Q2 2020.